Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
World J Clin Cases ; 10(1): 268-274, 2022 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-35071527

RESUMEN

BACKGROUND: Well-differentiated liposarcoma is the second most common pathologic type of retroperitoneal sarcoma. It is characterized by a huge mass, but multiple organ invasions are common. Surgery is the only treatment option for potential cure. Hyper-accuracy three-dimensional (3D) reconstruction is widely used in robotic partly nephrectomy owing to its ability to visualize overlapping anatomy. CASE SUMMARY: A 54-year-old man was admitted for progressive abdominal distension over the preceding 2 mo. Computed tomography revealed a 32 cm × 21 cm × 12 cm lipomatous mass. Hyper-accuracy 3D reconstruction was performed because of the complex relationship between the mass and nearby tissue. The patient underwent surgical resection, and the tumor did not recur for over 16 mo. CONCLUSION: Hyper-accuracy 3D reconstruction is useful for operative planning owing to its intuitiveness and precise determination of anatomical structures in both tumors and nearby tissues.

2.
World J Gastroenterol ; 25(38): 5789-5799, 2019 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-31636472

RESUMEN

BACKGROUND: Hepatocellular carcinoma (HCC) has become a great threat for people's health. Many long noncoding RNAs are involved in the pathogenesis of HCC. SNHG15, as a tissue specific long noncoding RNAs, has been studied in many human cancers, except HCC. AIM: To explore the regulatory mechanism of SNHG15 in HCC. METHODS: In the present research, 101 HCC patient samples, two HCC cell lines and one normal liver cell line were used. RT-qPCR and Western blot analysis were applied to detect SNHG15, miR-490-3p and histone deacetylase 2 (HDAC2) expression. The regulatory mechanism of SNHG15 was investigated using CCK-8, Transwell and luciferase reporter assays. RESULTS: Our research showed that up-regulation of SNHG15 was found in HCC and was related to aggressive behaviors in HCC patients. Moreover, knockdown of SNHG15 restrained HCC cell proliferation, migration and invasion. In addition, SNHG15 served as a molecular sponge for miR-490-3p. Further, miR-490-3p directly targets HDAC2. HDAC2 was involved in HCC progression by interacting with the SNHG15/miR-490-3p axis. CONCLUSION: In conclusion, long noncoding RNA SNHG15 promotes HCC progression by mediating the miR-490-3p/HDAC2 axis in HCC.


Asunto(s)
Carcinoma Hepatocelular/genética , Regulación Neoplásica de la Expresión Génica , Histona Desacetilasa 2/genética , Neoplasias Hepáticas/genética , MicroARNs/genética , ARN Largo no Codificante/metabolismo , Anciano , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Movimiento Celular/genética , Proliferación Celular/genética , Transición Epitelial-Mesenquimal/genética , Femenino , Perfilación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Humanos , Hígado/patología , Neoplasias Hepáticas/patología , Masculino , MicroARNs/metabolismo , Persona de Mediana Edad , ARN Largo no Codificante/genética , Regulación hacia Arriba
3.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 25(4): 351-3, 2009 Apr.
Artículo en Chino | MEDLINE | ID: mdl-19351510

RESUMEN

AIM: To study the mechanism of cinobufacin-induced apoptosis in BIU87 cell. METHODS: Growth inhibition of bladder cancer cells in vitro were estimated using MTT assay. Apoptotic cells were detected by in-situ cell apoptosis detection kit, and confirmed by flow cytometry. The mRNA level affected by cinobufacin was determined with RT-PCR. Caspase-3 activity was estimated with chromometry. RESULTS: Cinobufacin inhibited the proliferation of BIU87 cells and induced apoptosis. More than 50% cells were killed with 0.2 mg/L of cinobufacin for 72 h. S-phase and G2-phase arrest was induced. There were significant changes of Bcl-2, caspase-3 mRNA and caspase-3 activity; while no changes of bax was found. CONCLUSION: Cinobufacin can inhibit the proliferation of BIU87 cells by inducting apoptosis, which may be related with S- and G2-phase arrest, down-regulation of Bcl-2, and increasing caspase-3 expression and its activity.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Caspasa 3/genética , Caspasa 3/metabolismo , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Fase G2/efectos de los fármacos , Concentración 50 Inhibidora , Microscopía Fluorescente , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Fase S/efectos de los fármacos , Factores de Tiempo , Neoplasias de la Vejiga Urinaria/genética , Neoplasias de la Vejiga Urinaria/metabolismo , Neoplasias de la Vejiga Urinaria/patología , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA